RFA-HL-26-012: NIH StARR (R38) 2026-2027 Funding for Residency Research Programs

RFA-HL-26-012: NIH StARR (R38) 2026-2027 Funding for Residency Research Programs

NIH StARR is not a standard fellowship and it is not a personal research award for an individual resident. It is an institutional opportunity built to help residency programs produce clinician-investigators. The program’s core idea is simple: if a residency program can give promising postdoctoral-level health professionals protected, mentored research time early in training, it can strengthen the pipeline into careers that mix clinical work with basic, clinical, and translational research.

That makes this opportunity especially useful for teaching hospitals, academic medical centers, and other residency programs that already have enough research depth to support mentoring, compliance, and long-term tracking. The 2026 cycle is active, the 2027 deadline is already listed in the corrected key dates, and the announcement remains open through January 2028. For institutions planning ahead, this is a real FY 2026/2027 program rather than a one-off notice.

Key details at a glance

The accessible summary page does not publish a simple one-line award ceiling, so do not plan around an assumed dollar cap. Treat the official announcement as the source of truth for allowable costs, budget structure, and any institute-specific expectations.

What StARR is designed to fund

StARR is a research-in-residency pipeline program. The aim is not just to let residents “do some research.” It is to create structured, mentored research experiences early enough in training that the resident can move toward an investigator career instead of drifting away from research because clinical demands crowd it out.

The program supports institutional programs that recruit and retain resident-investigators. The institutional part matters. NIH is looking for a programmatic model: mentoring, research planning, skills development, and a pathway toward later career development awards. That means your application should read like a residency research system, not a single project proposal.

The official summary describes the target population as postdoctoral-level health professionals in residency training. The program’s purpose is to give them in-depth research experience while they are still in the training pipeline. That makes it valuable for departments that want to strengthen future faculty recruitment, not just produce a one-year training activity.

Another important point: this is a clinical research career program, but the RFA is marked “Independent Clinical Trial Not Allowed.” Applicants should not build a proposal around launching their own standalone clinical trial. Instead, they should focus on mentored research experiences, research skills, and structured development.

Who should consider applying

This is a good fit if your institution can answer yes to most of these questions:

• Do you run residency training programs with a real research culture?
• Can you identify resident-investigators who are likely to benefit from protected research time?
• Do you have faculty mentors who can supervise research, methods, and career planning?
• Can your grants office and residency leadership handle institutional reporting and compliance?
• Can you show that the program will improve the pipeline into clinician-investigator careers?

The most natural applicants are academic medical centers, teaching hospitals, and universities with affiliated residency programs. The simpler Grants.gov listing also shows broad applicant categories, but the program’s purpose is clearly institutional. The application should therefore be built around department-level support, mentor capacity, and long-term resident development rather than a one-off trainee experience.

If you are an individual resident looking for a personal stipend or a short-term project grant, this is probably not the right fit. The award is aimed at the residency program level, and the benefits flow through the institution to the resident-investigators selected under the program.

Eligibility and institutional requirements

The official opportunity listing makes the eligibility rules clear enough to avoid guesswork:

• foreign organizations are not eligible,
• non-domestic components of U.S. organizations are not eligible,
• foreign components are not allowed,
• eligible applicants include the organization categories listed on the opportunity page.

In practice, that means U.S.-based institutions should verify both organizational eligibility and internal residency-program readiness before they build a submission. If your institution has research strength but no reliable mentoring structure, you are not ready yet.

Because this is a residency research program, reviewers will also want to see that you can support residents in a realistic clinical environment. That usually means:

1. protected time,
2. faculty mentors with relevant methods expertise,
3. a plan for project selection and milestone tracking,
4. a way to manage the balance between service obligations and research progress,
5. and administrative support for the full award period.

The resident-investigator part of the program matters too. The goal is to support health professionals who are already in postdoctoral-level training and help them move toward independence. If your applicant narrative never explains how residents will be selected, supported, and tracked, it will look incomplete.

How the 2026 and 2027 deadlines work

The corrected key dates matter because they show that this is not just a one-year opportunity. The announcement is active in 2026, and the notice of correction lists due dates in 2026 and 2027.

For planning purposes:

• the 2026 application due date is 2026-10-13,
• the 2027 application due date is also listed for 2027-10-13,
• the announcement expires on 2028-01-11.

That gives institutions enough runway to decide whether to move quickly for the 2026 cycle or use the year ahead to build a stronger 2027 submission. In practical terms, the later date is useful for programs that need time to line up mentors, resident cohorts, protected-time models, and internal approvals.

The deadline timing also matters for academic calendars. Many residency programs make staffing and recruitment decisions months in advance, so you should not wait until the fall deadline to begin internal preparation. If you want to apply in 2026, start building the program architecture now: mentor commitments, trainee identification, and institutional letters should be settled well before the final month.

What a competitive application should show

A strong StARR application needs to do more than repeat the program mission. It should prove that your residency environment can actually produce clinician-investigators.

Reviewers will usually look for four things:

1. A credible resident pipeline

Show where the resident-investigators will come from, how they will be selected, and why they are likely to succeed. This should include evidence that the institution already attracts trainees with research interest or can realistically create that pipeline.

2. Strong mentorship depth

StARR lives or dies on mentor quality. You need faculty who can guide project design, methods, ethics, data handling, and long-term career development. A list of names is not enough; explain how mentorship will be structured and how often it will happen.

3. Protected research time and operational support

This is a residency program, so clinical demands can easily overwhelm the research plan. The application should spell out how residents will get protected time, how that time will be supervised, and how the program will prevent research from becoming optional when the clinical schedule gets busy.

4. A transition plan into independence

The program’s purpose is to build future clinician-investigators. That means your application should show how residents will move from mentored research into the next stage: career development applications, faculty roles, additional grant preparation, or sustained research collaboration.

If you can connect those four pieces, the proposal becomes much stronger than a generic training narrative.

How to prepare before you submit

The application process will follow standard NIH and Grants.gov mechanics, but your internal prep should be more specialized than that. Start with the program design, then fill in the forms.

First, confirm the applicant structure. Because the opportunity is institutional, you need a clear lead organization, a defined administrative owner, and a clinical or residency champion. If those roles are not aligned early, the application can stall in internal review.

Second, document mentor readiness. A successful program will have faculty who can explain what they will supervise, how often they will meet with residents, and what kinds of research experiences are realistic in a residency schedule. NIH reviewers can usually tell when mentorship is vague.

Third, make the resident experience concrete. Spell out what a typical year looks like: selection, onboarding, mentor assignment, methods training, milestones, and progress reviews. If your narrative treats the resident year as a blank box, it will read as weak.

Fourth, check your budget and compliance logic against the full announcement. Because the accessible summary page does not provide a simple award maximum, your institution should not invent one. Budget only after you have verified the official instructions and your own institutional indirect-cost and personnel rules.

Finally, build an internal review around the actual program goal. Ask whether the proposal truly advances clinician-investigator development or whether it is just a research side project attached to residency training. That distinction matters.

Common mistakes to avoid

The most common mistake is treating StARR like a personal trainee award. It is not. The institution has to show program structure, not just one strong resident candidate.

Another common error is overpromising clinical trial activity. The mechanism is explicitly “Independent Clinical Trial Not Allowed.” If the core concept depends on a new standalone trial, the proposal is misaligned from the start.

Programs also stumble when they ignore the residency context. A research plan that looks good on paper can fail in practice if it does not respect call schedules, service obligations, and the realities of clinical training.

Other avoidable problems include:

• weak mentor assignments,
• vague resident selection rules,
• no clear transition from residency research to later career development,
• missing institutional support,
• and assuming foreign components can be added later.

If you are unsure whether your organization is ready, take that as a signal to slow down rather than forcing the submission.

FAQ

Is this a fellowship for individual residents?

No. It is an institutional grant opportunity for residency programs that support resident-investigators.

Can a program use this to fund a standalone clinical trial?

No. The mechanism is marked independent clinical trial not allowed.

Does the summary page show a simple award cap?

Not in the accessible listing. Check the full announcement before you budget.

Who is the program trying to help?

Resident-investigators who are postdoctoral-level health professionals and institutions that want to build clinician-investigator pipelines.

Is the 2027 deadline already known?

Yes. The corrected key dates list a 2027 due date of 2027-10-13.

Can foreign organizations apply?

No. Foreign organizations and foreign components are not eligible.

Official links and next steps

Use the official sources directly:

• Grants.gov opportunity listing: https://simpler.grants.gov/opportunity/359130
• NIH RFA page: https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-012.html
• Correction notice for key dates: https://www.grants.nih.gov/grants/guide/notice-files/NOT-HL-25-031.html

If you are deciding whether to pursue the 2026 or 2027 cycle, the best next step is to map your residency program against the three core questions this opportunity asks:

1. Can we provide protected research time?
2. Can we mentor resident-investigators well enough to move them toward independence?
3. Can we run the program as an institution, not just as a one-off project?

If the answer to all three is yes, this is a strong opportunity to track.